Pacific Biosciences of California Gestione
Gestione criteri di controllo 2/4
Pacific Biosciences of California Il CEO è Christian O. Henry, nominato in Sep2020, e ha un mandato di 4.17 anni. la retribuzione annua totale è $ 8.05M, composta da 8.6% di stipendio e 91.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.14% delle azioni della società, per un valore di $ 668.18K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.2 anni e 11.8 anni.
Informazioni chiave
Christian O. Henry
Amministratore delegato
US$8.0m
Compenso totale
| Percentuale dello stipendio del CEO | 8.6% |
| Mandato del CEO | 4.2yrs |
| Proprietà del CEO | 0.1% |
| Durata media del management | 4.2yrs |
| Durata media del Consiglio di amministrazione | 11.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Pacific Biosciences' Cost Cuts Won't Offset Rising Competition
Nov 12Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company
Nov 07
Health Check: How Prudently Does Pacific Biosciences of California (NASDAQ:PACB) Use Debt?
Oct 16Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely
Sep 20Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing
Aug 21Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper
Jul 02We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt
Jun 08Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas
Jun 03These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat
Apr 25It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks
Apr 16Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
Mar 19Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth
Feb 08With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For
Feb 01What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S
Dec 18Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?
Nov 13The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%
Aug 28Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?
Jul 31Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Jul 06Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt
May 25Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Mar 29Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?
Feb 26Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$394m |
| Jun 30 2024 | n/a | n/a | -US$400m |
| Mar 31 2024 | n/a | n/a | -US$297m |
| Dec 31 2023 | US$8m | US$695k | -US$307m |
| Sep 30 2023 | n/a | n/a | -US$309m |
| Jun 30 2023 | n/a | n/a | -US$319m |
| Mar 31 2023 | n/a | n/a | -US$321m |
| Dec 31 2022 | US$7m | US$667k | -US$314m |
| Sep 30 2022 | n/a | n/a | -US$299m |
| Jun 30 2022 | n/a | n/a | -US$206m |
| Mar 31 2022 | n/a | n/a | -US$175m |
| Dec 31 2021 | US$3m | US$650k | -US$181m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$77m |
| Mar 31 2021 | n/a | n/a | -US$59m |
| Dec 31 2020 | US$13m | US$195k | US$29m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$51m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$100k | n/a | -US$84m |
| Sep 30 2019 | n/a | n/a | -US$115m |
| Jun 30 2019 | n/a | n/a | -US$111m |
| Mar 31 2019 | n/a | n/a | -US$109m |
| Dec 31 2018 | US$88k | n/a | -US$103m |
Compensazione vs Mercato: La retribuzione totale di Christian O. ($USD 8.05M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 2.24M ).
Compensazione vs guadagni: La retribuzione di Christian O. è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Christian O. Henry (56 yo)
4.2yrs
Mandato
US$8,046,575
Compensazione
Mr. Christian O. Henry, MBA, served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He has been President and Chief Executive Officer at Pacific Biosciences o...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 4.2yrs | US$8.05m | 0.14% $ 668.2k | |
| Chief Financial Officer | 4.2yrs | US$2.52m | 0.043% $ 203.4k | |
| Chief Operating Officer | 3.8yrs | US$4.60m | 0.12% $ 544.2k | |
| Co-Founder | 24.3yrs | US$466.76k | Nessun dato | |
| VP & Chief Accounting Officer | 3.5yrs | Nessun dato | 0.013% $ 62.3k | |
| General Counsel & Corporate Secretary | no data | Nessun dato | Nessun dato | |
| Chief People Officer | no data | Nessun dato | Nessun dato |
4.2yrs
Durata media
51yo
Età media
Gestione esperta: Il team dirigenziale di PACB è considerato esperto (durata media dell'incarico 4.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 6.3yrs | US$8.05m | 0.14% $ 668.2k | |
| Independent Director | 20.8yrs | US$259.00k | 0.0069% $ 32.3k | |
| Independent Director | 12.2yrs | US$255.00k | 0% $ 0 | |
| Independent Chairman | 11.3yrs | US$297.00k | 0.040% $ 189.2k | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 15.8yrs | US$265.00k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Chairman of Scientific Advisory Board | 2yrs | Nessun dato | Nessun dato |
11.8yrs
Durata media
70yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di PACB è composto da personale esperto e esperto (durata media dell'incarico 11.8 anni).